Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Pediatric Dermatology
|
March 8, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE)
Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz, et al.
Pediatric Dermatology
|
May 18, 2023
Rubella virus-associated necrotizing granulomatous inflammation with extensive eyelid, ocular, and orbital involvement
Matthew A Pimentel, Donna H Kim, Lorne W Walker, et al.
JAMA Dermatology
|
February 16, 2022
Development and Initial Validation of a Novel System to Assess Ichthyosis Severity
Qisi Sun, Sarah Asch, Cheryl Bayart, et al.
Pediatric Dermatology
|
February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial
Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.
JAMA Dermatology
|
April 24, 2024
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders
Amy S Paller, Stephanie M Rangel, Sarah L Chamlin, et al.
The Journal of Pediatrics
|
January 13, 2024
Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10
Mitchell Braun, Ilona J Frieden, Dawn H Siegel, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Pediatric Dermatology
|
March 8, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE)
Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz, et al.
Pediatric Dermatology
|
May 18, 2023
Rubella virus-associated necrotizing granulomatous inflammation with extensive eyelid, ocular, and orbital involvement
Matthew A Pimentel, Donna H Kim, Lorne W Walker, et al.
JAMA Dermatology
|
February 16, 2022
Development and Initial Validation of a Novel System to Assess Ichthyosis Severity
Qisi Sun, Sarah Asch, Cheryl Bayart, et al.
Pediatric Dermatology
|
February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial
Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.
JAMA Dermatology
|
April 24, 2024
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders
Amy S Paller, Stephanie M Rangel, Sarah L Chamlin, et al.
The Journal of Pediatrics
|
January 13, 2024
Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10
Mitchell Braun, Ilona J Frieden, Dawn H Siegel, et al.
Page
of 4